Symeres and Axxam To Offer an Innovative Compound Library for High-Throughput Screens

 Nijmegen (the Netherlands) and Bresso (Italy)- 9th December 2020

Symeres and Axxam have further consolidated their strategic relationship, providing integrated drug discovery and development services to clients around the world, by announcing the transfer of a library of approx. 80,000 lead-like compounds, Symegold, to Axxam for use in high-throughput screens.

Scroll to top